Jump to content

David Cooper (immunologist)

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by EmausBot (talk | contribs) at 23:21, 18 June 2016 (Bot: Migrating 1 interwiki links, now provided by Wikidata on d:Q24682145). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

David Albert Cooper AO[1] (born 1949) is an Australian HIV/AIDS researcher, immunologist, professor at the University of New South Wales, and the director of the Kirby Institute. He diagnosed the first case of HIV in Australia.

Career

Cooper received a Bachelor of Science from the University of Sydney in 1969 and an MBBS from Sydney Medical School in 1972. After completing his residency at St Vincent's Hospital, he was awarded a postgraduate research scholarship by the University of New South Wales (UNSW) to study immunology. In 1975 he went to Tucson, Arizona, where he was a research fellow at the University of Arizona Medical Center. He then returned to St Vincent's Hospital in Sydney and was promoted to an immunology staff specialist in 1979.[2]

Cooper travelled to Boston, Massachusetts, as a research fellow in cancer immunology in 1981—the beginning of the outbreak of HIV/AIDS in the United States.[2] Having seen the symptoms of HIV/AIDS in young gay men in the U.S., Cooper returned to Australia and resumed his role at St Vincent's Hospital, where he recognised the same illness in young Australian men who had recently travelled to the U.S. He is credited with diagnosing the first case of HIV in Australia[3] after publishing a case report on a man with HIV seroconversion illness in The Lancet in 1985. He was awarded a Doctor of Medicine by UNSW in 1983 and appointed a senior lecturer at the university in 1986. In the same year he was named director of the newly founded National Centre in HIV Epidemiology and Clinical Research (now the Kirby Institute).[2]

In 1991 he was named chair of the WHO Global Program in AIDS committee on clinical research and drug development, and in 1994 he was appointed a full professor and awarded a Doctor of Science by UNSW.[2] In 1996 he and two other HIV/AIDS researchers, the Dutch Joep Lange and Thai Praphan Phanuphak, founded a research centre in Bangkok named HIVNAT (HIV Netherlands Australia Thailand Research Collaboration).[3] Cooper, Lange and Phanuphak also established a program to increase access to antiretroviral drugs to treat HIV in Cambodia.[2]

Cooper has directed the Kirby Institute since its establishment in 1986.[4] He is also a past president of the International AIDS Society.[5]

Honours

Cooper was made an Officer of the Order of Australia (AO) in 2003 for his contribution to medicine and HIV/AIDS research.[2] He was elected as a fellow of the Australian Academy of Science in 2007[1] and the Australian Academy of Health and Medical Sciences in 2015.[6]

References

  1. ^ a b "Fellows Elected in 2007". Australian Academy of Science. Retrieved 13 June 2016.
  2. ^ a b c d e f Mellor, Lise (2008). "Cooper, David Albert". Sydney Medical School. Retrieved 13 June 2016.
  3. ^ a b Sommer, Belinda (22 May 2015). "Professor David Cooper on fighting HIV/AIDS for three decades". ABC News. Retrieved 13 June 2016.
  4. ^ "About the Kirby Institute". Kirby Institute. Retrieved 13 June 2016.
  5. ^ Wainberg, Mark (2004). "Antiretroviral Drug Access in the Developing World: An Expert Interview With David Cooper, MD". Medscape. Retrieved 13 June 2016.
  6. ^ "Professor David Cooper announced as inaugural Fellow of the Australian Academy of Health and Medical Sciences" (Press release). Kirby Institute. 8 April 2015. Retrieved 13 June 2016.
Retrieved from "https://en.wikipedia.org/w/index.php?title=David_Cooper_(immunologist)&oldid=725948668"